An atypical lipoteichoic acid from Clostridium perfringens elicits a broadly cross-reactive and protective immune response

J Biol Chem. 2020 Jul 10;295(28):9513-9530. doi: 10.1074/jbc.RA119.009978. Epub 2020 May 18.

Abstract

Clostridium perfringens is a leading cause of food-poisoning and causes avian necrotic enteritis, posing a significant problem to both the poultry industry and human health. No effective vaccine against C. perfringens is currently available. Using an antiserum screen of mutants generated from a C. perfringens transposon-mutant library, here we identified an immunoreactive antigen that was lost in a putative glycosyltransferase mutant, suggesting that this antigen is likely a glycoconjugate. Following injection of formalin-fixed whole cells of C. perfringens HN13 (a laboratory strain) and JGS4143 (chicken isolate) intramuscularly into chickens, the HN13-derived antiserum was cross-reactive in immunoblots with all tested 32 field isolates, whereas only 5 of 32 isolates were recognized by JGS4143-derived antiserum. The immunoreactive antigens from both HN13 and JGS4143 were isolated, and structural analysis by MALDI-TOF-MS, GC-MS, and 2D NMR revealed that both were atypical lipoteichoic acids (LTAs) with poly-(β1→4)-ManNAc backbones substituted with phosphoethanolamine. However, although the ManNAc residues in JGS4143 LTA were phosphoethanolamine-modified, a few of these residues were instead modified with phosphoglycerol in the HN13 LTA. The JGS4143 LTA also had a terminal ribose and ManNAc instead of ManN in the core region, suggesting that these differences may contribute to the broadly cross-reactive response elicited by HN13. In a passive-protection chicken experiment, oral challenge with C. perfringens JGS4143 lead to 22% survival, whereas co-gavage with JGS4143 and α-HN13 antiserum resulted in 89% survival. This serum also induced bacterial killing in opsonophagocytosis assays, suggesting that HN13 LTA is an attractive target for future vaccine-development studies.

Keywords: Clostridium perfringens; Gram-positive bacteria; NMR spectroscopy; carbohydrate biosynthesis; carbohydrate structure; cell surface; cell wall; food safety; foodborne illness; glycobiology; glycoconjugate; glycoconjugate vaccines; glycolipid structure; lipoteichoic acid (LTA); microbial pathogenesis; microbiology; necrotic enteritis; one health.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Chickens* / immunology
  • Chickens* / microbiology
  • Clostridium Infections* / immunology
  • Clostridium Infections* / prevention & control
  • Clostridium perfringens* / chemistry
  • Clostridium perfringens* / immunology
  • Humans
  • Lipopolysaccharides* / chemistry
  • Lipopolysaccharides* / immunology
  • Lipopolysaccharides* / pharmacology
  • Poultry Diseases* / immunology
  • Poultry Diseases* / microbiology
  • Poultry Diseases* / prevention & control
  • Teichoic Acids* / chemistry
  • Teichoic Acids* / immunology
  • Teichoic Acids* / pharmacology

Substances

  • Lipopolysaccharides
  • Teichoic Acids
  • lipoteichoic acid